The surge in insider selling at Invesco Ltd. (NYSE:IVZ) is picking up steam with the current sell/buy ratio now at 1.26. IVZ recorded 4 sales on the open market in the last three months. They sold nearly 89,162 shares while purchases amounted to 70,762 shares that period. Looking even further back to 12 months, corporate insiders offloaded 1,230,245 shares when buyers snapped up 1,148,776 shares. The 12-month’s totals signify about a 1.07-to-1 sell/buy ratio.
Flanagan Martin L parted with a total of 422.86 thousand shares of Invesco Ltd. (IVZ) at average share price of $33.12. This insider trade in the company took place on 03/15/2018. The total for the sales was set at $14.01 million. After this transaction, the President & CEO account balance stood at 675.97 thousand shares. The stock lost -47.52 percent since that insider sale. On 03/09/2018, Lege Annette, Chief Accounting Officer, sold 5 thousand shares at a price per share of $34.31. This removed 171.55 thousand shares from the insider’s fortune and the stock saw a -49.34 percent retreat in value since the news became public. This transaction left 57.83 thousand shares in the Chief Accounting Officer account.
On 02/27/2018, Director Beshar Sarah performed a purchase transaction worth $98.96 thousand. This purchase at $33.32 each has added 2.97 thousand shares into the insider’s portfolio position. Meanwhile, shares have recorded -47.84 percent decrease since the transaction was reported. The insider now is left with 8.84 thousand shares remaining in the account. Carome Kevin M, who performs the SMD and General Counsel job, sold 25 thousand shares for $834.5 thousand. The disposal occurred on 02/15/2018 was priced at $33.38 per share. The share price plunged -47.93 percent since the reporting date. Carome Kevin M now left with a stake of 465.86 thousand IVZ stock worth $8.1 million after the insider selling.
The 12-month median price target for Invesco Ltd. (IVZ) assigned by the analysts stands at $19, which represents a return potential of 9.32 percent when compared to the closing price of the stock of $17.38 on Friday, January 11. The lowest price target for the stock is $17 — slightly more than -2.19 percent from IVZ’s current share price. The stock will probably climb 20.14 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $30-month high price target. This represents a whopping 72.61 percent increase from where shares are trading today.
On momentum oscillators front, ‘RSI’ has touched 46.91 on daily chart, which may remain a cause for concern. If the price breaks below $16.83 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $17.65 mark may result into a pull-back move towards $17.93 level. The stock is currently hovering around the first support level of $17.1. Below this, the next support is placed in the zone of $16.83. Till the time, the IVZ stock trades above this level, bulls have nothing to fear.
Shares of Invesco Ltd. (IVZ) are trading at a P/E ratio of 8.08 times earnings reported for the past 12 months. The industry IVZ operates in has an average P/E of 229.55. Its P/E ratio went as low as 14.74X and as high as 18.64 over the 5-year span. Further, it is sporting a 1.33 on the Price-to-Sales ratio. Compare this with the industry average P/S of 52.72. 70.1 percent is the gross profit margin for Invesco Ltd. and operating margin sits at 24.3 percent. Along with this, the net profit margin is 21.7 percent.
On 11th of January, Invesco Ltd. (NYSE:IVZ) shares ended lower after a volatile session. The shares dropped -0.17 points or -0.97 percent at $17.38 with a light trade volume of 6.079 million shares. After opening the session at $17.28, the shares went as high as $17.65 and as low as $17.1, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $7.22 billion and now has 415.36 million shares outstanding. Invesco Ltd. (IVZ) stock has lost -0.11 percent of market value in 21 trading days.
IVZ stock has a trailing 3-year beta of 1.51, offering the possibility of a higher rate of return, but also posing more risk. The portion of a company’s profit allocated to each outstanding share of common stock was $2.54 a share in the trailing twelve months. The stock’s value has surged 3.82 percent year to date (YTD) against a decline of -52.8 percent in 12 month’s time. The company’s shares still trade -54.77 percent away from its 1-year high of $38.43 and 13 percent up from 52-week low of $15.38. The average consensus rating on the company is 2.6, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a sell.